Cidara Therapeutics’ main value driver, CD388, recently achieved an impressive 76% protection in its Phase 2b trials. See why ...

10. “You shall not covet your neighbor’s wife; and you shall not desire your neighbor’s house, his field, his male servant, his female servant, his ox, his donkey, or anything that is your neighbor’s.

In previous treat-to-target trials, adjustments to the dose of basal insulin have been made at least weekly, according to ...